Ellen De Pauw

Ellen De Pauw

Auto-generated profile, based on publicly available information

Ellen De Pauw

Transportation Research Institute, Hasselt University, Wetenschapspark 5, BE-3590 Diepenbeek, Belgium

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Accident Analysis & Prevention
Verified
Journal Article
Closed access
EPEllen De Pauw
Ellen De Pauw
SDStijn Daniels
Stijn Daniels
MTMelissa Thierie
Melissa Thierie
Tom BrijsTom Brijs
Tom Brijs

1 December 2014 in Accident Analysis & Prevention
Verified
Journal Article
Closed access
EPEllen De Pauw
Ellen De Pauw
SDStijn Daniels
Stijn Daniels
Tom BrijsTom Brijs
Tom Brijs
EHElke Hermans
Elke Hermans
GWGeert Wets
Geert Wets

1 December 2014 in Accident Analysis & Prevention
Verified
Journal Article
Closed access
EPEllen De Pauw
Ellen De Pauw
SDStijn Daniels
Stijn Daniels
Tom BrijsTom Brijs
Tom Brijs
EHElke Hermans
Elke Hermans
GWGeert Wets
Geert Wets

1 May 2014 in Accident Analysis & Prevention
Verified
Journal Article
Closed access
EPEllen De Pauw
Ellen De Pauw
SDStijn Daniels
Stijn Daniels
Tom BrijsTom Brijs
Tom Brijs
EHElke Hermans
Elke Hermans
GWGeert Wets
Geert Wets

1 September 2014 in Journal of Safety Research
Verified
Journal Article
Closed access
EPEllen De Pauw
Ellen De Pauw
SDStijn Daniels
Stijn Daniels
Tom BrijsTom Brijs
Tom Brijs
EHElke Hermans
Elke Hermans
GWGeert Wets
Geert Wets

14 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
TWTine Van Win
Tine Van Win
WBWannes Brangers
Wannes Brangers
EPEllen De Pauw
Ellen De Pauw
Agustin Resendiz-SharpeAgustin Resendiz-Sharpe
Agustin Resendiz-Sharpe
GWGert-Jan Wijnant
Gert-Jan Wijnant
EAEmmanuel André
Emmanuel André
Mycobacterium avium pulmonary disease is an emerging global health challenge for which drug development remains limited by preclinical models that rely on laboratory strains and invasive endpoint analyses. Here, we compared recent clinical M. avium isolates with the reference strain ATCC 700898 across macrophage, Galleria mellonella , and murine infection models and evaluated longitudinal micro-computed tomography (µCT) as a non-invasive tool to monitor disease progression and treatment response. While extracellular growth rates were comparable, clinical isolates demonstrated enhanced host-associated fitness and induced higher bacterial burdens and more severe pulmonary pathology in mice than the reference strain. These strain-dependent differences were detected by quantitative µCT imaging. Using the hypervirulent isolate MYC_0069, we further show that clarithromycin monotherapy and standard-of-care triple therapy significantly reduced bacterial burden and lung pathology. Together, these findings establish a clinically relevant chronic M. avium model that combines clinical isolates with longitudinal imaging to enable preclinical anti-mycobacterial drug evaluation in vivo .